Medicina
Departamento
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicaciones en colaboración con investigadoras/es de GlaxoSmithKline (United Kingdom) (8)
2023
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases
The Lancet Rheumatology
-
Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study
Reumatologia Clinica, Vol. 19, Núm. 6, pp. 312-318
2022
-
What are the prospects for antiplatelet agents for thromboprophylaxis in antiphospholipid syndrome?
Expert Review of Clinical Immunology
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2006
-
Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae
Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 3, pp. 536-545
2003
-
Oral pharmacokinetically enhanced co-amoxiclav 2000/125 mg, twice daily, compared with co-amoxiclav 875/125 mg, three times daily, in the treatment of community-acquired pneumonia in European adults
Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 5, pp. 826-836
1997
-
Eficacia y seguridad de la nabumetona en el tratamiento de la gonartrosis: Ensayo clinico comparativo con aceclofenaco
Medicina Clinica, Vol. 109, Núm. 4, pp. 130-134